GERRESHEIMER AG (GXI.DE) Stock Fundamental Analysis

FRA:GXI • DE000A0LD6E6

19.89 EUR
+0.86 (+4.52%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Overall GXI gets a fundamental rating of 3 out of 10. We evaluated GXI against 18 industry peers in the Life Sciences Tools & Services industry. GXI may be in some trouble as it scores bad on both profitability and health. GXI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • GXI had positive earnings in the past year.
  • GXI had a positive operating cash flow in the past year.
  • In the past 5 years GXI has always been profitable.
  • Each year in the past 5 years GXI had a positive operating cash flow.
GXI.DE Yearly Net Income VS EBIT VS OCF VS FCFGXI.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.50%, GXI is doing worse than 80.95% of the companies in the same industry.
  • GXI's Return On Equity of 1.67% is on the low side compared to the rest of the industry. GXI is outperformed by 76.19% of its industry peers.
  • GXI has a worse Return On Invested Capital (2.79%) than 80.95% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for GXI is below the industry average of 9.81%.
Industry RankSector Rank
ROA 0.5%
ROE 1.67%
ROIC 2.79%
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
GXI.DE Yearly ROA, ROE, ROICGXI.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • The Profit Margin of GXI (1.04%) is worse than 80.95% of its industry peers.
  • In the last couple of years the Profit Margin of GXI has remained more or less at the same level.
  • GXI has a Operating Margin of 5.99%. This is amonst the worse of the industry: GXI underperforms 80.95% of its industry peers.
  • In the last couple of years the Operating Margin of GXI has grown nicely.
  • The Gross Margin of GXI (26.89%) is worse than 76.19% of its industry peers.
  • In the last couple of years the Gross Margin of GXI has remained more or less at the same level.
Industry RankSector Rank
OM 5.99%
PM (TTM) 1.04%
GM 26.89%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
GXI.DE Yearly Profit, Operating, Gross MarginsGXI.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GXI is destroying value.
  • GXI has about the same amout of shares outstanding than it did 1 year ago.
  • GXI has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, GXI has a worse debt to assets ratio.
GXI.DE Yearly Shares OutstandingGXI.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
GXI.DE Yearly Total Debt VS Total AssetsGXI.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of 0.92, we must say that GXI is in the distress zone and has some risk of bankruptcy.
  • GXI's Altman-Z score of 0.92 is on the low side compared to the rest of the industry. GXI is outperformed by 76.19% of its industry peers.
  • GXI has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.
  • GXI's Debt to Equity ratio of 1.22 is on the low side compared to the rest of the industry. GXI is outperformed by 61.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Altman-Z 0.92
ROIC/WACC0.36
WACC7.78%
GXI.DE Yearly LT Debt VS Equity VS FCFGXI.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • GXI has a Current Ratio of 0.98. This is a bad value and indicates that GXI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • GXI's Current ratio of 0.98 is on the low side compared to the rest of the industry. GXI is outperformed by 71.43% of its industry peers.
  • A Quick Ratio of 0.52 indicates that GXI may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.52, GXI is doing worse than 71.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.52
GXI.DE Yearly Current Assets VS Current LiabilitesGXI.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • GXI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.08%.
  • The Earnings Per Share has been decreasing by -8.23% on average over the past years.
  • GXI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.83%.
  • The Revenue has been growing slightly by 7.90% on average over the past years.
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%

3.2 Future

  • GXI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.90% yearly.
  • Based on estimates for the next years, GXI will show a small growth in Revenue. The Revenue will grow by 6.41% on average per year.
EPS Next Y-38.18%
EPS Next 2Y-19.95%
EPS Next 3Y-6.67%
EPS Next 5Y4.9%
Revenue Next Year13.03%
Revenue Next 2Y8.75%
Revenue Next 3Y7.84%
Revenue Next 5Y6.41%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
GXI.DE Yearly Revenue VS EstimatesGXI.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
GXI.DE Yearly EPS VS EstimatesGXI.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 5.39, which indicates a rather cheap valuation of GXI.
  • 100.00% of the companies in the same industry are more expensive than GXI, based on the Price/Earnings ratio.
  • GXI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.68.
  • The Price/Forward Earnings ratio is 6.63, which indicates a rather cheap valuation of GXI.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of GXI indicates a rather cheap valuation: GXI is cheaper than 100.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, GXI is valued rather cheaply.
Industry RankSector Rank
PE 5.39
Fwd PE 6.63
GXI.DE Price Earnings VS Forward Price EarningsGXI.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 95.24% of the companies in the same industry are more expensive than GXI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.83
GXI.DE Per share dataGXI.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • A cheap valuation may be justified as GXI's earnings are expected to decrease with -6.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-19.95%
EPS Next 3Y-6.67%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.21%, GXI is not a good candidate for dividend investing.
  • GXI's Dividend Yield is slightly below the industry average, which is at 0.45.
  • Compared to an average S&P500 Dividend Yield of 1.84, GXI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.21%

5.2 History

  • The dividend of GXI has a limited annual growth rate of 0.94%.
Dividend Growth(5Y)0.94%
Div Incr Years0
Div Non Decr Years6
GXI.DE Yearly Dividends per shareGXI.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 10.12% of the earnings are spent on dividend by GXI. This is a low number and sustainable payout ratio.
  • The dividend of GXI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP10.12%
EPS Next 2Y-19.95%
EPS Next 3Y-6.67%
GXI.DE Yearly Income VS Free CF VS DividendGXI.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M
GXI.DE Dividend Payout.GXI.DE Dividend Payout, showing the Payout Ratio.GXI.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GERRESHEIMER AG

FRA:GXI (2/13/2026, 7:00:00 PM)

19.89

+0.86 (+4.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-13
Earnings (Next)02-26
Inst Owners98.9%
Inst Owner ChangeN/A
Ins Owners4.92%
Ins Owner ChangeN/A
Market Cap687.00M
Revenue(TTM)2.25B
Net Income(TTM)23.35M
Analysts66.36
Price Target38.42 (93.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.21%
Yearly Dividend1.32
Dividend Growth(5Y)0.94%
DP10.12%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.39%
Min EPS beat(2)-6.69%
Max EPS beat(2)1.92%
EPS beat(4)3
Avg EPS beat(4)7.96%
Min EPS beat(4)-6.69%
Max EPS beat(4)18.84%
EPS beat(8)5
Avg EPS beat(8)4.68%
EPS beat(12)8
Avg EPS beat(12)3.75%
EPS beat(16)9
Avg EPS beat(16)2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.48%
Min Revenue beat(2)-2.11%
Max Revenue beat(2)-0.85%
Revenue beat(4)0
Avg Revenue beat(4)-1.32%
Min Revenue beat(4)-2.11%
Max Revenue beat(4)-0.72%
Revenue beat(8)1
Avg Revenue beat(8)-0.95%
Revenue beat(12)3
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)-0.33%
PT rev (3m)-4.19%
EPS NQ rev (1m)-21.05%
EPS NQ rev (3m)-21.05%
EPS NY rev (1m)-6.57%
EPS NY rev (3m)-7.6%
Revenue NQ rev (1m)0.35%
Revenue NQ rev (3m)0.35%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.34%
Valuation
Industry RankSector Rank
PE 5.39
Fwd PE 6.63
P/S 0.31
P/FCF N/A
P/OCF 2.71
P/B 0.49
P/tB N/A
EV/EBITDA 6.83
EPS(TTM)3.69
EY18.55%
EPS(NY)3
Fwd EY15.08%
FCF(TTM)-2.51
FCFYN/A
OCF(TTM)7.34
OCFY36.92%
SpS65.15
BVpS40.59
TBVpS-8.95
PEG (NY)N/A
PEG (5Y)N/A
Graham Number58.05
Profitability
Industry RankSector Rank
ROA 0.5%
ROE 1.67%
ROCE 3.76%
ROIC 2.79%
ROICexc 2.93%
ROICexgc 5.89%
OM 5.99%
PM (TTM) 1.04%
GM 26.89%
FCFM N/A
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
ROICexc(3y)6.5%
ROICexc(5y)6.42%
ROICexgc(3y)14.47%
ROICexgc(5y)16.32%
ROCE(3y)8.29%
ROCE(5y)8.2%
ROICexgc growth 3Y-17.1%
ROICexgc growth 5Y-18.13%
ROICexc growth 3Y-1.3%
ROICexc growth 5Y1.06%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Debt/EBITDA 4.4
Cap/Depr 134.54%
Cap/Sales 15.12%
Interest Coverage 1.65
Cash Conversion 65.42%
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.52
Altman-Z 0.92
F-Score4
WACC7.78%
ROIC/WACC0.36
Cap/Depr(3y)167.14%
Cap/Depr(5y)152.09%
Cap/Sales(3y)15.92%
Cap/Sales(5y)14.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
EPS Next Y-38.18%
EPS Next 2Y-19.95%
EPS Next 3Y-6.67%
EPS Next 5Y4.9%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
Revenue Next Year13.03%
Revenue Next 2Y8.75%
Revenue Next 3Y7.84%
Revenue Next 5Y6.41%
EBIT growth 1Y-34.26%
EBIT growth 3Y10.54%
EBIT growth 5Y10.8%
EBIT Next Year91.04%
EBIT Next 3Y32.27%
EBIT Next 5Y19.75%
FCF growth 1Y-1073.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.63%
OCF growth 3Y4.26%
OCF growth 5Y4.49%

GERRESHEIMER AG / GXI.DE FAQ

What is the ChartMill fundamental rating of GERRESHEIMER AG (GXI.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to GXI.DE.


What is the valuation status for GXI stock?

ChartMill assigns a valuation rating of 6 / 10 to GERRESHEIMER AG (GXI.DE). This can be considered as Fairly Valued.


How profitable is GERRESHEIMER AG (GXI.DE) stock?

GERRESHEIMER AG (GXI.DE) has a profitability rating of 3 / 10.


What is the expected EPS growth for GERRESHEIMER AG (GXI.DE) stock?

The Earnings per Share (EPS) of GERRESHEIMER AG (GXI.DE) is expected to decline by -38.18% in the next year.


How sustainable is the dividend of GERRESHEIMER AG (GXI.DE) stock?

The dividend rating of GERRESHEIMER AG (GXI.DE) is 3 / 10 and the dividend payout ratio is 10.12%.